Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 35 entries
Sorted by: Best Match Show Resources per page
Stem cells as drug delivery methods: application of stem cell secretome for regeneration.

Advanced drug delivery reviews

Tran C, Damaser MS.
PMID: 25451858
Adv Drug Deliv Rev. 2015 Mar;82:1-11. doi: 10.1016/j.addr.2014.10.007. Epub 2014 Oct 15.

Mesenchymal stem cells (MSCs) are a unique cell population defined by their ability to indefinitely self-renew, differentiate into multiple cell lineages, and form clonal cell populations. It was originally thought that this ability for broad plasticity defined the therapeutic...

Cite
Tran C, Damaser MS. Stem cells as drug delivery methods: application of stem cell secretome for regeneration. Adv Drug Deliv Rev. 2014;82:1-11doi: 10.1016/j.addr.2014.10.007.
Tran, C., & Damaser, M. S. (2015). Stem cells as drug delivery methods: application of stem cell secretome for regeneration. Advanced drug delivery reviews, 821-11. https://doi.org/10.1016/j.addr.2014.10.007
Tran, Christine, and Damaser, Margot S. "Stem cells as drug delivery methods: application of stem cell secretome for regeneration." Advanced drug delivery reviews vol. 82 (2015): 1-11. doi: https://doi.org/10.1016/j.addr.2014.10.007
Tran C, Damaser MS. Stem cells as drug delivery methods: application of stem cell secretome for regeneration. Adv Drug Deliv Rev. 2015 Mar;82:1-11. doi: 10.1016/j.addr.2014.10.007. Epub 2014 Oct 15. PMID: 25451858; PMCID: PMC4398586.
Copy Download .nbib Format: NLM
Advances in tissue engineering.

Journal of pediatric surgery

Langer R, Vacanti J.
PMID: 26711689
J Pediatr Surg. 2016 Jan;51(1):8-12. doi: 10.1016/j.jpedsurg.2015.10.022. Epub 2015 Nov 10.

Nearly 30 years ago, we reported on a concept now known as Tissue Engineering. Here, we report on some of the advances in this now thriving area of research. In particular, significant advances in tissue engineering of skin, liver,...

Cite
Langer R, Vacanti J. Advances in tissue engineering. J Pediatr Surg. 2015;51(1):8-12doi: 10.1016/j.jpedsurg.2015.10.022.
Langer, R., & Vacanti, J. (2016). Advances in tissue engineering. Journal of pediatric surgery, 51(1), 8-12. https://doi.org/10.1016/j.jpedsurg.2015.10.022
Langer, Robert, and Vacanti, Joseph. "Advances in tissue engineering." Journal of pediatric surgery vol. 51,1 (2016): 8-12. doi: https://doi.org/10.1016/j.jpedsurg.2015.10.022
Langer R, Vacanti J. Advances in tissue engineering. J Pediatr Surg. 2016 Jan;51(1):8-12. doi: 10.1016/j.jpedsurg.2015.10.022. Epub 2015 Nov 10. PMID: 26711689; PMCID: PMC4733916.
Copy Download .nbib Format: NLM
Regenerative medicine: is this the biggest change in surgery?.

Seminars in pediatric surgery

De Coppi P, Grikscheit TC.
PMID: 24994522
Semin Pediatr Surg. 2014 Jun;23(3):103-5. doi: 10.1053/j.sempedsurg.2014.04.001. Epub 2014 Apr 18.

No abstract available.

Cite
De Coppi P, Grikscheit TC. Regenerative medicine: is this the biggest change in surgery?. Semin Pediatr Surg. 2014;23(3):103-5doi: 10.1053/j.sempedsurg.2014.04.001.
De Coppi, P., & Grikscheit, T. C. (2014). Regenerative medicine: is this the biggest change in surgery?. Seminars in pediatric surgery, 23(3), 103-5. https://doi.org/10.1053/j.sempedsurg.2014.04.001
De Coppi, Paolo, and Grikscheit, T C. "Regenerative medicine: is this the biggest change in surgery?." Seminars in pediatric surgery vol. 23,3 (2014): 103-5. doi: https://doi.org/10.1053/j.sempedsurg.2014.04.001
De Coppi P, Grikscheit TC. Regenerative medicine: is this the biggest change in surgery?. Semin Pediatr Surg. 2014 Jun;23(3):103-5. doi: 10.1053/j.sempedsurg.2014.04.001. Epub 2014 Apr 18. PMID: 24994522.
Copy Download .nbib Format: NLM
Peers call for UK to harness "enormous" potential of regenerative medicine.

BMJ (Clinical research ed.)

O'Dowd A.
PMID: 23818565
BMJ. 2013 Jul 01;347:f4248. doi: 10.1136/bmj.f4248.

No abstract available.

Cite
O'Dowd A. Peers call for UK to harness "enormous" potential of regenerative medicine. BMJ. 2013;347:f4248doi: 10.1136/bmj.f4248.
O'Dowd, A. (2013). Peers call for UK to harness "enormous" potential of regenerative medicine. BMJ (Clinical research ed.), 347f4248. https://doi.org/10.1136/bmj.f4248
O'Dowd, Adrian. "Peers call for UK to harness "enormous" potential of regenerative medicine." BMJ (Clinical research ed.) vol. 347 (2013): f4248. doi: https://doi.org/10.1136/bmj.f4248
O'Dowd A. Peers call for UK to harness "enormous" potential of regenerative medicine. BMJ. 2013 Jul 01;347:f4248. doi: 10.1136/bmj.f4248. PMID: 23818565.
Copy Download .nbib Format: NLM
Tissue therapeutics and regenerative medicine.

Drug discovery today

Jayasinghe SN.
PMID: 24735731
Drug Discov Today. 2014 Jun;19(6):711-3. doi: 10.1016/j.drudis.2014.04.003. Epub 2014 Apr 13.

No abstract available.

Cite
Jayasinghe SN. Tissue therapeutics and regenerative medicine. Drug Discov Today. 2014;19(6):711-3doi: 10.1016/j.drudis.2014.04.003.
Jayasinghe, S. N. (2014). Tissue therapeutics and regenerative medicine. Drug discovery today, 19(6), 711-3. https://doi.org/10.1016/j.drudis.2014.04.003
Jayasinghe, Suwan N. "Tissue therapeutics and regenerative medicine." Drug discovery today vol. 19,6 (2014): 711-3. doi: https://doi.org/10.1016/j.drudis.2014.04.003
Jayasinghe SN. Tissue therapeutics and regenerative medicine. Drug Discov Today. 2014 Jun;19(6):711-3. doi: 10.1016/j.drudis.2014.04.003. Epub 2014 Apr 13. PMID: 24735731.
Copy Download .nbib Format: NLM
Targeted Near-Infrared Fluorescence Imaging for Regenerative Medicine.

Tissue engineering and regenerative medicine

Yang C, Park GK, McDonald EJ, Choi HS.
PMID: 31624699
Tissue Eng Regen Med. 2019 Sep 24;16(5):433-442. doi: 10.1007/s13770-019-00219-6. eCollection 2019 Oct.

BACKGROUND: Advances in tissue engineering and regenerative medicine over the last three decades have made great progress in the development of diagnostic and therapeutic methodologies for damaged tissues. However, regenerative medicine is still not the first line of treatment...

Cite
Yang C, Park GK, McDonald EJ, et al. Targeted Near-Infrared Fluorescence Imaging for Regenerative Medicine. Tissue Eng Regen Med. 2019;16(5):433-442doi: 10.1007/s13770-019-00219-6.
Yang, C., Park, G. K., McDonald, E. J., & Choi, H. S. (2019). Targeted Near-Infrared Fluorescence Imaging for Regenerative Medicine. Tissue engineering and regenerative medicine, 16(5), 433-442. https://doi.org/10.1007/s13770-019-00219-6
Yang, Chengeng, et al. "Targeted Near-Infrared Fluorescence Imaging for Regenerative Medicine." Tissue engineering and regenerative medicine vol. 16,5 (2019): 433-442. doi: https://doi.org/10.1007/s13770-019-00219-6
Yang C, Park GK, McDonald EJ, Choi HS. Targeted Near-Infrared Fluorescence Imaging for Regenerative Medicine. Tissue Eng Regen Med. 2019 Sep 24;16(5):433-442. doi: 10.1007/s13770-019-00219-6. eCollection 2019 Oct. PMID: 31624699; PMCID: PMC6778577.
Copy Download .nbib Format: NLM
Dedifferentiation, transdifferentiation, and reprogramming: future directions in regenerative medicine.

Seminars in reproductive medicine

Eguizabal C, Montserrat N, Veiga A, Izpisua Belmonte JC.
PMID: 23329641
Semin Reprod Med. 2013 Jan;31(1):82-94. doi: 10.1055/s-0032-1331802. Epub 2013 Jan 17.

The main goal of regenerative medicine is to replace damaged tissue. To do this it is necessary to understand in detail the whole regeneration process including differentiated cells that can be converted into progenitor cells (dedifferentiation), cells that can...

Cite
Eguizabal C, Montserrat N, Veiga A, et al. Dedifferentiation, transdifferentiation, and reprogramming: future directions in regenerative medicine. Semin Reprod Med. 2013;31(1):82-94doi: 10.1055/s-0032-1331802.
Eguizabal, C., Montserrat, N., Veiga, A., & Izpisua Belmonte, J. C. (2013). Dedifferentiation, transdifferentiation, and reprogramming: future directions in regenerative medicine. Seminars in reproductive medicine, 31(1), 82-94. https://doi.org/10.1055/s-0032-1331802
Eguizabal, Cristina, et al. "Dedifferentiation, transdifferentiation, and reprogramming: future directions in regenerative medicine." Seminars in reproductive medicine vol. 31,1 (2013): 82-94. doi: https://doi.org/10.1055/s-0032-1331802
Eguizabal C, Montserrat N, Veiga A, Izpisua Belmonte JC. Dedifferentiation, transdifferentiation, and reprogramming: future directions in regenerative medicine. Semin Reprod Med. 2013 Jan;31(1):82-94. doi: 10.1055/s-0032-1331802. Epub 2013 Jan 17. PMID: 23329641.
Copy Download .nbib Format: NLM
[The current status and future perspective of tissue engineering and regenerative medicine].

Nihon rinsho. Japanese journal of clinical medicine

Yamato M.
PMID: 22242304
Nihon Rinsho. 2011 Dec;69(12):2098-101.

No abstract available.

Cite
Yamato M. [The current status and future perspective of tissue engineering and regenerative medicine]. Nihon Rinsho. 2011;69(12):2098-101
Yamato, M. (2011). [The current status and future perspective of tissue engineering and regenerative medicine]. Nihon rinsho. Japanese journal of clinical medicine, 69(12), 2098-101.
Yamato, Masayuki. "[The current status and future perspective of tissue engineering and regenerative medicine]." Nihon rinsho. Japanese journal of clinical medicine vol. 69,12 (2011): 2098-101.
Yamato M. [The current status and future perspective of tissue engineering and regenerative medicine]. Nihon Rinsho. 2011 Dec;69(12):2098-101. Japanese. PMID: 22242304.
Copy Download .nbib Format: NLM
Global strategic partnerships in regenerative medicine.

Trends in biotechnology

French A, Suh JY, Suh CY, Rubin L, Barker R, Bure K, Reeve B, Brindley DA.
PMID: 25150363
Trends Biotechnol. 2014 Sep;32(9):436-40. doi: 10.1016/j.tibtech.2014.05.007.

The approach to research and development in biomedical science is changing. Increasingly, academia and industry seek to collaborate, and share resources and expertise, by establishing partnerships. Here, we explore the co-development partnership landscape in the field of regenerative medicine,...

Cite
French A, Suh JY, Suh CY, et al. Global strategic partnerships in regenerative medicine. Trends Biotechnol. 2014;32(9):436-40doi: 10.1016/j.tibtech.2014.05.007.
French, A., Suh, J. Y., Suh, C. Y., Rubin, L., Barker, R., Bure, K., Reeve, B., & Brindley, D. A. (2014). Global strategic partnerships in regenerative medicine. Trends in biotechnology, 32(9), 436-40. https://doi.org/10.1016/j.tibtech.2014.05.007
French, Anna, et al. "Global strategic partnerships in regenerative medicine." Trends in biotechnology vol. 32,9 (2014): 436-40. doi: https://doi.org/10.1016/j.tibtech.2014.05.007
French A, Suh JY, Suh CY, Rubin L, Barker R, Bure K, Reeve B, Brindley DA. Global strategic partnerships in regenerative medicine. Trends Biotechnol. 2014 Sep;32(9):436-40. doi: 10.1016/j.tibtech.2014.05.007. PMID: 25150363.
Copy Download .nbib Format: NLM
Hybrid microfabrication of nanofiber-based sheets and rods for tissue engineering applications.

Journal of laboratory automation

Park SH, Kim MS, Lee D, Choi YW, Kim DH, Suh KY.
PMID: 24022173
J Lab Autom. 2013 Dec;18(6):494-503. doi: 10.1177/2211068213500961. Epub 2013 Sep 10.

Electrospun nanofibers have been developed into a variety of forms for tissue engineering scaffolds to regulate the cellular functions guided by nanotopographical cues. Here, we have successfully fabricated nanofiber-based scaffold complexes of rod and sheet type by combining the...

Cite
Park SH, Kim MS, Lee D, et al. Hybrid microfabrication of nanofiber-based sheets and rods for tissue engineering applications. J Lab Autom. 2013;18(6):494-503doi: 10.1177/2211068213500961.
Park, S. H., Kim, M. S., Lee, D., Choi, Y. W., Kim, D. H., & Suh, K. Y. (2013). Hybrid microfabrication of nanofiber-based sheets and rods for tissue engineering applications. Journal of laboratory automation, 18(6), 494-503. https://doi.org/10.1177/2211068213500961
Park, Suk-Hee, et al. "Hybrid microfabrication of nanofiber-based sheets and rods for tissue engineering applications." Journal of laboratory automation vol. 18,6 (2013): 494-503. doi: https://doi.org/10.1177/2211068213500961
Park SH, Kim MS, Lee D, Choi YW, Kim DH, Suh KY. Hybrid microfabrication of nanofiber-based sheets and rods for tissue engineering applications. J Lab Autom. 2013 Dec;18(6):494-503. doi: 10.1177/2211068213500961. Epub 2013 Sep 10. PMID: 24022173.
Copy Download .nbib Format: NLM
Concise Review: The U.S. Food and Drug Administration and Regenerative Medicine.

Stem cells translational medicine

Witten CM, McFarland RD, Simek SL.
PMID: 26494784
Stem Cells Transl Med. 2015 Dec;4(12):1495-9. doi: 10.5966/sctm.2015-0098. Epub 2015 Oct 22.

UNLABELLED: Regenerative medicine (RM) is a popular term for a field of scientific and medical research. There is not one universally accepted definition of RM, but it is generally taken to mean the translation of multidisciplinary biology and engineering...

Cite
Witten CM, McFarland RD, Simek SL. Concise Review: The U.S. Food and Drug Administration and Regenerative Medicine. Stem Cells Transl Med. 2015;4(12):1495-9doi: 10.5966/sctm.2015-0098.
Witten, C. M., McFarland, R. D., & Simek, S. L. (2015). Concise Review: The U.S. Food and Drug Administration and Regenerative Medicine. Stem cells translational medicine, 4(12), 1495-9. https://doi.org/10.5966/sctm.2015-0098
Witten, Celia M, et al. "Concise Review: The U.S. Food and Drug Administration and Regenerative Medicine." Stem cells translational medicine vol. 4,12 (2015): 1495-9. doi: https://doi.org/10.5966/sctm.2015-0098
Witten CM, McFarland RD, Simek SL. Concise Review: The U.S. Food and Drug Administration and Regenerative Medicine. Stem Cells Transl Med. 2015 Dec;4(12):1495-9. doi: 10.5966/sctm.2015-0098. Epub 2015 Oct 22. PMID: 26494784; PMCID: PMC4675507.
Copy Download .nbib Format: NLM
Understanding and leveraging cell metabolism to enhance mesenchymal stem cell transplantation survival in tissue engineering and regenerative medicine applications.

Stem cells (Dayton, Ohio)

Salazar-Noratto GE, Luo G, Denoeud C, Padrona M, Moya A, Bensidhoum M, Bizios R, Potier E, Logeart-Avramoglou D, Petite H.
PMID: 31408238
Stem Cells. 2020 Jan;38(1):22-33. doi: 10.1002/stem.3079. Epub 2019 Oct 25.

In tissue engineering and regenerative medicine, stem cell-specifically, mesenchymal stromal/stem cells (MSCs)-therapies have fallen short of their initial promise and hype. The observed marginal, to no benefit, success in several applications has been attributed primarily to poor cell survival...

Cite
Salazar-Noratto GE, Luo G, Denoeud C, et al. Understanding and leveraging cell metabolism to enhance mesenchymal stem cell transplantation survival in tissue engineering and regenerative medicine applications. Stem Cells. 2019;38(1):22-33doi: 10.1002/stem.3079.
Salazar-Noratto, G. E., Luo, G., Denoeud, C., Padrona, M., Moya, A., Bensidhoum, M., Bizios, R., Potier, E., Logeart-Avramoglou, D., & Petite, H. (2020). Understanding and leveraging cell metabolism to enhance mesenchymal stem cell transplantation survival in tissue engineering and regenerative medicine applications. Stem cells (Dayton, Ohio), 38(1), 22-33. https://doi.org/10.1002/stem.3079
Salazar-Noratto, Giuliana E, et al. "Understanding and leveraging cell metabolism to enhance mesenchymal stem cell transplantation survival in tissue engineering and regenerative medicine applications." Stem cells (Dayton, Ohio) vol. 38,1 (2020): 22-33. doi: https://doi.org/10.1002/stem.3079
Salazar-Noratto GE, Luo G, Denoeud C, Padrona M, Moya A, Bensidhoum M, Bizios R, Potier E, Logeart-Avramoglou D, Petite H. Understanding and leveraging cell metabolism to enhance mesenchymal stem cell transplantation survival in tissue engineering and regenerative medicine applications. Stem Cells. 2020 Jan;38(1):22-33. doi: 10.1002/stem.3079. Epub 2019 Oct 25. PMID: 31408238.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 35 entries